Scarica l'app Stockscreener
0.903
5.40%
0.0463
Dopo l'orario di chiusura:
.88
-0.023
-2.55%
Precedente Chiudi:
$0.8567
Aprire:
$0.83
Volume 24 ore:
257.11K
Relative Volume:
0.60
Capitalizzazione di mercato:
$17.66M
Reddito:
$411.00K
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-2.0523
EPS:
-0.44
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
+7.50%
1M Prestazione:
-24.12%
6M Prestazione:
-33.11%
1 anno Prestazione:
-70.87%
Intervallo 1D:
$0.83
$0.9246
Intervallo di 1 settimana:
$0.8019
$0.99
Portata 52W:
$0.7749
$3.15
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Nome
Lexaria Bioscience Corp
Settore
Industria
Telefono
250-765-6424
Indirizzo
100 - 740 MCCURDY ROAD, KELOWNA
Confronta LEXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.903 | 19.04M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lexaria Bioscience Corp Borsa (LEXX) Ultime notizie
What catalysts could drive Lexaria Bioscience Corp. stock higherShort Setup & Real-Time Chart Breakout Alerts - newser.com
Price action breakdown for Lexaria Bioscience Corp. Equity WarrantCEO Change & Daily Stock Trend Reports - newser.com
Combining machine learning predictions for Lexaria Bioscience Corp. Equity WarrantJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com
Can trapped investors hope for a rebound in Lexaria Bioscience Corp. Equity WarrantPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
How Lexaria Bioscience Corp. stock performs in rising dollar environmentJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Is Lexaria Bioscience Corp. Equity Warrant stock in correction or buying zone2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Is Lexaria Bioscience Corp. stock ready for a breakoutAnalyst Upgrade & Low Drawdown Investment Strategies - newser.com
Will Lexaria Bioscience Corp. Equity Warrant outperform the marketTrade Risk Summary & Technical Buy Zone Confirmations - newser.com
Earnings visualization tools for Lexaria Bioscience Corp. Equity Warrant2025 Valuation Update & Safe Capital Growth Tips - newser.com
Can Lexaria Bioscience Corp. hit a new high this monthMarket Risk Analysis & Smart Allocation Stock Reports - newser.com
Lexaria expands pharmaceutical outreach with new advisory firm By Investing.com - Investing.com Nigeria
Lexaria Bioscience Corp. Provides Strategic Update - NewMediaWire
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents - TipRanks
Lexaria (LEXX) Expands R&D Efforts with Enhanced Funding and New Partnerships - GuruFocus
Lexaria expands pharmaceutical outreach with new advisory firm - Investing.com India
$4.0M Financing backs Lexaria's global BD push; 4 new patents bolster DehydraTECH R&D into 2026 - Stock Titan
Can trapped investors hope for a rebound in Lexaria Bioscience Corp.2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Historical volatility pattern of Lexaria Bioscience Corp. visualized2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Custom watchlist performance reports with Lexaria Bioscience Corp.2025 Major Catalysts & Pattern Based Trade Signal System - newser.com
News impact scoring models applied to Lexaria Bioscience Corp. Equity WarrantMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Can swing trading help recover from Lexaria Bioscience Corp. Equity Warrant losses2025 Key Lessons & Weekly Top Gainers Alerts - newser.com
Lexaria Bioscience Corp Stock Analysis and ForecastAutomated Trading Signals & Explosive Capital Growth - earlytimes.in
Will Lexaria Bioscience Corp. see short term momentumMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
Lexaria Bioscience Corp. Equity Warrant stock daily chart insightsWeekly Risk Report & High Conviction Trade Alerts - newser.com
Real time social sentiment graph for Lexaria Bioscience Corp.Quarterly Trade Review & Technical Pattern Based Buy Signals - newser.com
Smart tools for monitoring Lexaria Bioscience Corp.’s price actionWeekly Market Outlook & Weekly Stock Performance Updates - newser.com
Can Lexaria Bioscience Corp. Equity Warrant stock deliver surprise earnings beatCPI Data & Fast Moving Trade Plans - newser.com
When is the best time to exit Lexaria Bioscience Corp.Entry Point & Community Verified Trade Signals - newser.com
Is Lexaria Bioscience Corp. stock reversal real or fakeAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
What drives Lexaria Bioscience Corp stock priceFundamental Stock Analysis & High Yield Trading Plans - earlytimes.in
Lexaria Bioscience Corp. Equity Warrant stock trendline breakdownWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com
What’s next for Lexaria Bioscience Corp. Equity Warrant stock price2025 Price Action Summary & Breakout Confirmation Alerts - newser.com
Chart based exit strategy for Lexaria Bioscience Corp. Equity WarrantJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Will earnings trigger a reversal in Lexaria Bioscience Corp.2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
LEXX: Biodistribution Study Results - Yahoo Finance
Lexaria Bioscience announces ~$4M registered direct offering of shares - MSN
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):